Inference of dynamic biological networks based on responses to drug perturbations

Drugs that target specific proteins are a major paradigm in cancer research. In this article, we extend a modeling framework for drug sensitivity prediction and combination therapy design based on drug perturbation experiments. The recently proposed target inhibition map approach can infer stationary pathway models from drug perturbation experiments, but the method is limited to a steady-state snapshot of the underlying dynamical model. We consider the inverse problem of possible dynamic models that can generate the static target inhibition map model. From a deterministic viewpoint, we analyze the inference of Boolean networks that can generate the observed binarized sensitivities under different target inhibition scenarios. From a stochastic perspective, we investigate the generation of Markov chain models that satisfy the observed target inhibition sensitivities.

[1]  B. Druker,et al.  Molecularly targeted therapy: have the floodgates opened? , 2004, The oncologist.

[2]  J. Mesirov,et al.  Chemosensitivity prediction by transcriptional profiling , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[3]  Jae K. Lee,et al.  A strategy for predicting the chemosensitivity of human cancers and its application to drug discovery , 2007, Proceedings of the National Academy of Sciences.

[4]  Howard A. Fine,et al.  Predicting in vitro drug sensitivity using Random Forests , 2011, Bioinform..

[5]  Laura Tolosi,et al.  Predicting drug susceptibility of non-small cell lung cancers based on genetic lesions. , 2009, The Journal of clinical investigation.

[6]  Ranadip Pal,et al.  Analyzing pathway design from drug perturbation experiments , 2012, 2012 IEEE Statistical Signal Processing Workshop (SSP).

[7]  Aniruddha Datta,et al.  Intervention in context-sensitive probabilistic Boolean networks , 2005, Bioinform..

[8]  Stuart A. Kauffman,et al.  The origins of order , 1993 .

[9]  T. Zhou,et al.  A Relative Variation-Based Method to Unraveling Gene Regulatory Networks , 2012, PloS one.

[10]  S. Ramaswamy,et al.  Systematic identification of genomic markers of drug sensitivity in cancer cells , 2012, Nature.

[11]  Mark R. Green,et al.  Targeting targeted therapy. , 2004, The New England journal of medicine.

[12]  S. Morrison,et al.  Heterogeneity in Cancer: Cancer Stem Cells versus Clonal Evolution , 2009, Cell.

[13]  N. D. Clarke,et al.  Towards a Rigorous Assessment of Systems Biology Models: The DREAM3 Challenges , 2010, PloS one.

[14]  C. Sander,et al.  Models from experiments: combinatorial drug perturbations of cancer cells , 2008, Molecular systems biology.

[15]  J. Sklar,et al.  Molecular Tumor Profiling for Prediction of Response to Anticancer Therapies , 2011, Cancer journal.

[16]  Kevan M Shokat,et al.  Features of selective kinase inhibitors. , 2005, Chemistry & biology.

[17]  Hidde de Jong,et al.  Modeling and Simulation of Genetic Regulatory Systems: A Literature Review , 2002, J. Comput. Biol..

[18]  Ranadip Pal,et al.  A new approach for prediction of tumor sensitivity to targeted drugs based on functional data , 2013, BMC Bioinformatics.

[19]  Ranadip Pal,et al.  A Kinase Inhibition Map Approach for Tumor Sensitivity Prediction and Combination Therapy Design for Targeted Drugs , 2011, Pacific Symposium on Biocomputing.

[20]  Adam A. Margolin,et al.  The Cancer Cell Line Encyclopedia enables predictive modeling of anticancer drug sensitivity , 2012, Nature.

[21]  C. Sawyers,et al.  Targeted cancer therapy , 2004, Nature.

[22]  Ranadip Pal,et al.  Context-Sensitive Probabilistic Boolean Networks: Steady-State Properties, Reduction, and Steady-State Approximation , 2010, IEEE Transactions on Signal Processing.

[23]  Tong Zhou,et al.  BIOINFORMATICS ORIGINAL PAPER , 2022 .

[24]  Ranadip Pal,et al.  Characterizing the Effect of Coarse-Scale PBN Modeling on Dynamics and Intervention Performance of Genetic Regulatory Networks Represented by Stochastic Master Equation Models , 2010, IEEE Transactions on Signal Processing.

[25]  Julio Saez-Rodriguez,et al.  Identifying Drug Effects via Pathway Alterations using an Integer Linear Programming Optimization Formulation on Phosphoproteomic Data , 2009, PLoS Comput. Biol..

[26]  John P. Overington,et al.  Can we rationally design promiscuous drugs? , 2006, Current opinion in structural biology.